X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (170) 170
infectious diseases (129) 129
female (120) 120
male (118) 118
index medicus (117) 117
adult (108) 108
tuberculosis (104) 104
hiv (94) 94
hiv infections - drug therapy (94) 94
south africa (72) 72
antiretroviral therapy (70) 70
immunology (62) 62
human immunodeficiency virus--hiv (61) 61
drug therapy (58) 58
middle aged (51) 51
anti-hiv agents - therapeutic use (48) 48
medicine, general & internal (45) 45
mortality (44) 44
antiretroviral drugs (43) 43
research (43) 43
hiv infections - complications (42) 42
risk factors (41) 41
hiv infection (37) 37
virology (37) 37
antiviral agents (34) 34
treatment outcome (34) 34
microbiology (33) 33
health aspects (32) 32
pharmacology & pharmacy (32) 32
adults (31) 31
therapy (31) 31
aids (30) 30
care and treatment (30) 30
highly active antiretroviral therapy (29) 29
dosage and administration (28) 28
acquired immune deficiency syndrome--aids (27) 27
analysis (27) 27
antitubercular agents - therapeutic use (27) 27
cd4 lymphocyte count (26) 26
efavirenz (26) 26
diagnosis (25) 25
medicine (25) 25
research article (25) 25
south africa - epidemiology (25) 25
aids/hiv (24) 24
human immunodeficiency virus (24) 24
cohort studies (23) 23
hiv-infected patients (23) 23
pharmacokinetics (23) 23
hiv infections - immunology (22) 22
hiv patients (22) 22
human-immunodeficiency-virus (22) 22
tuberculosis - complications (22) 22
tuberculosis - drug therapy (22) 22
drug resistance (21) 21
patients (21) 21
young adult (21) 21
anti-hiv agents - administration & dosage (20) 20
complications and side effects (20) 20
drug interactions (20) 20
hiv-1 (20) 20
prevalence (20) 20
south-africa (20) 20
studies (20) 20
viral load (20) 20
article (19) 19
hiv infections - virology (19) 19
prospective studies (19) 19
respiratory system (19) 19
adolescent (18) 18
anti-hiv agents - adverse effects (18) 18
cross-sectional studies (18) 18
disease (18) 18
hiv infections - epidemiology (18) 18
mycobacterium-tuberculosis (18) 18
prevention (18) 18
abridged index medicus (17) 17
adherence (17) 17
antiretroviral agents (17) 17
cd4 antigen (17) 17
anti-hiv agents - pharmacokinetics (16) 16
anti-retroviral agents - therapeutic use (16) 16
pharmacology (16) 16
pulmonary tuberculosis (16) 16
rifampin - therapeutic use (16) 16
risk-factors (16) 16
antiretroviral therapy, highly active (15) 15
drugs (15) 15
follow-up studies (15) 15
hiv infections - mortality (15) 15
infection (15) 15
patient compliance (15) 15
patient outcomes (15) 15
public health (15) 15
retrospective studies (15) 15
benzoxazines - therapeutic use (14) 14
lopinavir (14) 14
science (14) 14
usage (14) 14
africa (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 03/2016, Volume 387, Issue 10024, pp. 1211 - 1226
Summary Although the worldwide incidence of tuberculosis has been slowly decreasing, the global disease burden remains substantial (∼9 million cases and ∼1·5... 
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 03/2019
Journal Article
Lancet, ISSN 0140-6736, 12/2007, Volume 370, Issue 9604, pp. 2030 - 2043
Tuberculosis is still a leading cause of death in low-income and middle-income countries, especially those of sub-Saharan Africa where tuberculosis is an... 
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2008, Volume 8, Issue 8, pp. 516 - 523
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2013, Volume 8, Issue 5, p. e63623
Background: Lipoatrophy and/or central fat gain are observed frequently in patients on antiretroviral therapy (ART). Both are assumed to be antiretroviral... 
PROTEASE INHIBITOR | NUCLEOSIDE-SPARING REGIMEN | THYMIDINE ANALOG | MULTIDISCIPLINARY SCIENCES | MITOCHONDRIAL-FUNCTION | HIV-1-INFECTED PATIENTS | INFECTED PATIENTS | RANDOMIZED COMPARATIVE TRIAL | BODY-COMPOSITION | HUMAN-IMMUNODEFICIENCY-VIRUS | LIMB FAT | HIV Protease Inhibitors - adverse effects | Torso | Adiposity - drug effects | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Tomography, X-Ray Computed | Absorptiometry, Photon | Reverse Transcriptase Inhibitors - adverse effects | Drug-Related Side Effects and Adverse Reactions | Subcutaneous Fat - drug effects | Lipodystrophy - chemically induced | Intra-Abdominal Fat - drug effects | Lipodystrophy - diagnostic imaging | Complications and side effects | Highly active antiretroviral therapy | Care and treatment | Protease inhibitors | AIDS treatment | Proteases | DNA polymerases | Stavudine | Research | HIV (Viruses) | HIV infection | Antiretroviral drugs | Antiviral agents | RNA-directed DNA polymerase | Toxicity | Clinical trials | Proteinase inhibitors | Thymidine | Patients | Efavirenz | Antiretroviral therapy | Switching | Tenofovir | Side effects | Acquired immune deficiency syndrome--AIDS | Lipoatrophy | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Abacavir | Lipodystrophy | Zidovudine | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
2012, 3rd ed., ISBN 0199053669, xxiii, 644 p., [24] p. of plates
Book
Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 6, pp. 442 - 443
  Because this was a phase 2 trial that was not powered for comparison of regimens, a phase 3 trial is needed to compare the two doses of raltegravir in... 
Infectious Disease | Anti-HIV Agents - administration & dosage | Pyrrolidinones - administration & dosage | HIV-1 - drug effects | Humans | Tuberculosis - drug therapy | Female | HIV Infections - drug therapy | Male | Raltegravir Potassium | Drug therapy | Drug dosages | Human immunodeficiency virus--HIV
Journal Article
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 03/2019
Journal Article
PLoS Medicine, ISSN 1549-1277, 2011, Volume 8, Issue 1, p. e1000391
Journal Article
The Lancet, ISSN 0140-6736, 03/2016, Volume 387, Issue 10024, p. 1211
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(15)00151-8 Byline: Keertan Dheda, Clifton E Barry, Gary... 
Tuberculosis | Drug resistance
Journal Article